Obstructive sleep apnoea (OSA) is associated with an increased risk of all‐cause and cardiovascular mortality.1 Positive ...
Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.
Hosted on MSN24d
CPAP therapy may not improve neurocognition for some people with obstructive sleep apneaC ontinuous positive airway pressure (CPAP) therapy for obstructive sleep apnea is most effective in improving neurocognition in people who have a high arousal threshold, according to a new ...
Explore the intricate relationship between therapeutic CPAP pressures and obstructive sleep apnea severity in children, ...
Discover how obstructive sleep apnea increases Parkinson’s disease risk and how early CPAP therapy can significantly reduce the risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results